Login Register
icon_bulk_orderBulk order Acrobiosystems for ChineseChinese
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
SARS-CoV-2  lambda  Delta | Claudin 18.2 | CD20 | CD3 | FcR | IL-2R
0
There is no goods in the shopping cart !
My Cart
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Recombinant Proteins & Antibodies

  • Immune Checkpoint Proteins Immune Checkpoint Proteins
  • SPR-BLI-analytical-service
  • Claudin18.2 Proteins
  • good
  • CAR-specific Monoclonal Antibody to Detect Anti-CD19 CAR Expression
COVID-19 R&D

Where do we go from here: A reflection of COVID-19

Binding and neutralizing antibodies correlated with COVID-19 risk and vaccine efficacy

What You Should Know About the Lambda Variant

Accelerated Progress: Spike Protein Mutations on B.1.617 Identified and Studied

SARS-CoV-2 Mutants

Emerging VoCs, Lambda, Delta, Beta, Alpha mutants and so on, including RBD, S trimer, S1, NTD, NP, etc. These mutants are of high purity and bioactivity and can be used to evaluate the efficacy of the antibodies and vaccination.

SARS-CoV-2 Related Kits

ELISA kits for neutralizing antibody titer assay, binding antibody titer assay, antibody isotype assay, antigen titer assay and inhibitor screening, etc., which can accelerate the research and development of anti-SARS-CoV-2 drugs and vaccines.

Targets of CAR-T Cell Therapy

50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.                  

Full-length Transmembrane Proteins

Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2， CD133, GPRC5D，CCR8, CCR5, etc.

Targets for ADCs

A collection of targets for ADC development which are of high specificity and bioactivities and suitable for immunization, antibody screening, cell based assay, etc.

Immune Checkpoints

A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.

Cytokines

Comprehensive cytokines including IL families, growth factors, chemokines, TNFs, etc. These products are HEK293 expressed and nearly in authentic structure, high purity and bioactivity, cell based assay/SPR/BLI verified.

BsAb targets

CD3 proteins and a collection of for bispecific antibody development which are of high specificity and bioactivities and suitable for immunization, antibody screening.

Fc Receptors

Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.

MABSOL® Biotinylated Proteins

The MABSOL biotinylated protein collection includes more than a hundred commonly studied drug targets and biomarker proteins.

Enzymes

Series of target enzymes, including ATP related enzymes, protease, kinase, and tool enzymes, including Nuclease, IdeS, Endo S, etc.

Anti-idiotypic Antibodies

To support preclinical/clinical immunogenicity and PK analysis, ACROBiosystems has developed a series of high-affinity anti-idiotypic antibodies. Our pipeline covers five hot targets including adalimum*b, rituxim*b, cetuxim*b, trastuzum*b, and bevacizum*b.

Newly Added Products

Mutants from SARS-CoV-2 Emerging Variants Lambda and more

ACROBiosystems are going full steam ahead on developing a collection of recombinant antigens for emergency SARS-CoV-2 variants. The reagents can be used to evaluate the efficacy of the antibodies and vaccination.

Learn more

Full-length Multi-pass Transmembrane Proteins

We supply full-length multi-pass TPs with stabilized structure and high activity including CD20, Claudin18.2, CD133, GPRC5D, CCR5 and CCR8, which can be used in immunization, ELISA, SPR, BLI, cell experiment and CAR detection.

Learn more

News Center

Key Points of Antibody–Drug Conjugates (ADCs) Development
2021/08/31
Key Points of Antibody–Drug Conjugates (ADCs) Development
Antibody-drug conjugates (ADCs), an emerging class of targeted therapies that witnessed substantial growth over the past few years, are gradually starting the revolution of clinical cancer therapy.
Learn more
Where do we go from here: A reflection of COVID-19
2021/09/10
Where do we go from here: A reflection of COVID-19
Learn more
ACROBiosystems makes donations to BEI Resources, accelerating the process of attacking SARS-CoV-2 variants globally
2021/05/10
ACROBiosystems makes donations to BEI Resources, accelerating the process of attacking SARS-CoV-2 variants globally
Multiple SARS-CoV-2 variants are emerging and circulating globally; the battle against COVID-19 pandemic is still challenging. Recently, ACROBiosystems donated SARS-CoV-2 mutant proteins to BEI Resources, a NIAID funded bioresource program, joining in the collective effort in attacking SARS-CoV-2 va
Learn more
Landscape of Cancer Research Symposia
2021/09/29 - 2021/09/30
Landscape of Cancer Research Symposia
Speaker: Prajwal Paudel, PhD (ACROBio), Eric B. Kmiec, PhD, Jim Jackson, PhD, etc.
Time: September 29-30, 2021
Learn more

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
中文网站|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap